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Purpose: Interphotoreceptor retinol-binding protein (IRBP), composed of two or four homologous modules in tandem,
plays an important role in retinoid trafficking between the retinal pigmented epithelium, photoreceptors, and Müller cells.
The exact nature of this role is not yet clear. Attempts to purify the full-length retinal IRBP to homogeneity for
crystallization purposes have largely been unsuccessful, owing primarily to instability and denaturation of the protein at
high concentrations in aqueous media.
Methods: A bacterial expression system was used for the production of the recombinant full-length four modules-
containing Xenopus IRBP (xIRBP; 1197 amino acids; 131 kDa). An optimized purification strategy and the presence of
molar excesses of a thiol-based reducing agent yielded highly pure xIRBP in a soluble, stable and active form, free of its
fusion partner. Binding of all-trans retinol was characterized by fluorescence spectroscopy monitoring ligand-fluorescence
enhancement, quenching of endogenous protein fluorescence, and energy transfer.
Results: We grew the first diffraction-quality crystal of xIRBP. We have gathered diffraction data from these crystals to
2.46Å resolution, sufficient to yield an atomic model of the tertiary structure of IRBP. Retinol-binding results determined
by fluorescence spectroscopy show roughly one retinol-binding site per polypeptide chain.
Conclusions: The binding stoichiometry taken together with modeling data suggest that not all modules are functionally
equivalent. Determination of the full-length IRBP structure will be a significant breakthrough in understanding the
functional roles of IRBP in the visual cycle. The advances presented here will not only lead to the structure of the full-
length IRBP, but will allow us to understand how the modules interact in the function of IRBP. Furthermore, these studies
will allow characterization of the ligand-binding site(s) with bound ligand(s).
The functional significance of the module structure of
interphotoreceptor retinoid-binding protein (IRBP) remains
unknown. IRBP, roughly a 135 kDa (~1200 amino acids)
glycoprotein, is composed of four homologous “modules.”
Each are approximately 300 amino acids in length. Rods and
cones secrete IRBP into subretinal space, where it is the major
soluble protein component of the interphotoreceptor matrix
(IPM).  In  the  IPM,  IRBP  is  rapidly  turned  over  by  a
combination  of  retinal  pigmented  epithelium  (RPE)  and
photoreceptor endocytosis [1–3]. Although insight into its
structure,  cellular  physiology,  and  function  has  been
accumulating [4–8], progress is severely hampered by lack of
information about its complete three-dimensional structure.
IRBP is positioned to mediate interactions between cells
bordering the IPM. IRBP carries visual cycle retinoids in a
light-dependent manner, and was originally thought to only
solubilize retinoids in the IPM. Its role is rather complex as it
functions in four steps of the visual cycle: promoting (1) the
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removal of all-trans retinol from bleached rod outer segments
[9,10], (2) the delivery of all-trans retinol to the RPE [11], (3)
the release of 11-cis retinal from the RPE [12–14], and (4) the
delivery of 11-cis retinal to the outer segments [14]. The role
of IRBP in these steps, although sufficient, may not be strictly
necessary,  as  IRBP-deficient  mice  (transgenic  “knockout”
mice) do not show a depressed rate of retinoid exchange
between the retina and RPE [15]. The rate of recovery is more
rapid than that in controls [16,17]. This could be explained by
a buffering activity, a property that has been observed in
studies monitoring the exchange of retinoids between lipid
vesicles [18]. The importance of IRBP as a buffer may be
related to its biochemical activity in preventing oxidative and
isomeric  degradation  of  visual  cycle  retinoids  [19].  The
mechanism  of  IRBP’s  antioxidant  activity  is  not  known.
Finally, it should be mentioned that IRBP has been implicated
in  functions  outside  of  the  visual  cycle  including  retinal
development (reviewed in [5,8]), and fatty acid binding [20,
21]. The emerging picture is that IRBP has multiple functions
in the visual cycle, and probably has roles outside the cycle.
Understanding the mechanisms involved will require a clearer
picture of its structure.
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2275Xenopus  provides  a  particularly  useful  experimental
system to study the trafficking, and function of IRBP in the
visual cycle and in development. We have, thus, continued to
focus on Xenopus IRBP (xIRBP; 131 kDa; 1197 amino acids
without the signal peptide) as an alternative model for human
IRBP,  which  is  60%  identical  to  xIRBP  in  amino  acid
sequence. Furthermore, xIRBP is composed of four modules
that are homologous to that of mammalian and avian IRBPs
[22,23]. In the current study, we have overcome the problems
related  to  generating  IRBP  crystals.  Here,  we  extend  our
previous study [24] by preparing a full-length xIRBP in a
soluble  form  free  of  its  thioredoxin  (Trx)  fusion  partner,
establish conditions that allow for concentrating the protein
without  precipitation,  and  identify  conditions  that  permit
routine growth of diffraction quality crystals. These advances
will not only lead to the structure of the full-length IRBP, but
will also allow characterization of ligand-binding domain(s)
with bound ligand.
METHODS
Expression  of  the  recombinant  full-length  Xenopus
interphotoreceptor retinol-binding protein and purification
by  Ni-affinity  chromatography:  Preparation  of  the  clone
expressing xIRBP as a thioredoxin fusion protein that contains
a His-patch has been previously described [24]. The fusion
protein  DNA  was  sub-cloned  into  pThiohisA  vector
(Invitrogen, Carlsbad, CA); the bacterial cell used for protein
expression was Top10 (Invitrogen). Cell lysate in a binding
buffer of 25 mM Tris-HCl, pH 7.5 at 4 °C, containing 200 mM
NaCl and 1mM Dithiothreitol (DTT; Inalco, San Luis Obispo,
CA) was applied to a pre-equilibrated 5ml HisTrap HP column
(GE Healthcare, Piscataway, NJ). All purification columns
were run on an Äkta FPLC (GE Healthcare). Protein was
eluted over a 20-column volume linear gradient from 0 to
300 mM imidazole in an elution buffer composed of 25 mM
Tris-HCl, pH 7.5 at 4 °C, 50 mM NaCl, and 0.5 mM DTT. A
major protein peak eluted at 50 mM imidazole. The eluted
fractions  were  pooled,  and  the  protein  concentration  was
determined  by  measuring  the  optical  density  at  280  nm
(OD280) and by sodium dodecyl sulfate-PAGE (SDS–PAGE)
analysis performed with 12% Tris-HCl pre-cast gels (Bio-Rad
Laboratories, Hercules, CA). Pooled fractions were diluted
such that the imidazole concentration was 20 mM or less. To
remove  the  N-terminal  Trx  fragment,  we  added
EnterokinaseMax (EK; Invitrogen) in a ratio of 2 U EK to
1 mg protein. After incubation for ~36 h at 4 °C, EK was
removed using EK-Away resin (Invitrogen) according to the
manufacturer’s direction.
The cleaved xIRBP was then applied to a second 5 ml
HisTrap HP column (GE Healthcare) pre-equilibrated with
the binding buffer. The same chromatography method was
used on a Äkta FPLC (GE Healthcare). Protein was eluted
over a 20-column volume linear gradient from 0 to 300 mM
imidazole with the following elution buffer: 25 mM Tris-HCl,
pH 7.5 at 4 °C, 50 mM NaCl, and 0.5 mM DTT. While a part
of the cleaved xIRBP flowed through the column as expected,
some bound the column, presumably through the endogenous
histidine  side  chains,  and  eluted  as  a  major  peak  at  an
imidazole concentration of 60 mM. The bound fractions were
pooled,  and  the  protein  concentration  was  determined  by
SDS–PAGE  analysis,  and  absorbance  spectroscopy  using
extinction coefficients calculated from the primary sequence
[24]. Proteolysis was prevented by adding 0.4 mM Pefabloc
SC (Roche, Indianapolis, IN) to the pooled fractions.
Gel filtration: The DTT concentration of the protein solution
was  then  adjusted  to  1  mM,  and  resulting  solution  was
concentrated to a final volume of about 6 ml by ultrafiltration
using  a  YM-50  centricon  (Millipore,  Billerica,  MA).  The
protein  was  then  loaded  onto  a  previously  equilibrated
Sephacryl S-300HR (S300) column (GE Healthcare), which
measured 2.6 × 100 cm. The gel filtration procedure was run
on a Äkta FPLC with one column volume isocratic elution
using the following binding buffer: 25 mM Tris-HCl, pH 7.5
at 4 °C, 50 mM NaCl, and 1 mM DTT. xIRBP eluted as
dimeric as well as monomeric peaks, each of which were
pooled  and  analyzed  by  SDS–PAGE.  The  purest  xIRBP
fractions eluted as a dimer between elution volumes 212 and
250 ml. The procedure yielded 15 to 20 mg of ~97% pure
xIRBP from 1.25 L of cell culture.
Protein assay: Final IRBP-containing fractions were pooled,
and protein concentration was determined by OD280 and 12%
SDS–PAGE analysis.
N-terminal sequence: The xIRBP band from the SDS–PAGE
analysis was blotted onto a PVDF membrane. The band was
cut  out,  dried,  and  sent  to  Proseq  (Boxford,  MA)  for
sequencing by the Edman degradation method.
Crystallization: The buffer components of purified xIRBP
were adjusted to 50 mM Tris-HCl, pH7.5 at 4 °C, 100 mM
NaCl,  and  4  mM  DTT.  The  protein  solution  was  then
concentrated to12 mg/ml of xIRBP. At the final concentration,
0.5 mM oleic acid was added to the solution, and the mixture
was incubated. Crystal screening experiments were conducted
with  freshly  purified  xIRBP  using  the  MbClass  II  Suite
commercial  screen  (Qiagen/Nextal,  Montreal,  Canada)
cocktail solutions. The screening was performed at 23 °C in
24-well sitting drop plates. Crystals initially grew at 23 °C
from 0.1M MgCl2, 0.1M NaCl, 0.1 M Na HEPES pH 7.5, 12%
polyethylene  glycol  (PEG)  4000,  as  well  as  from  0.1M
MgCl2,  0.1  M  NaCl,  0.1M  3-(Cyclohexylamino)-2-
hydroxy-1-propanesulfonic acid (CAPSO); pH 9.5, 12% PEG
4000 when the protein and the reservoir (cocktail) solutions
were  mixed  in  1:1  ratio  and  the  resulting  droplets  were
allowed  to  undergo  vapor  diffusion  against  reservoirs  in
sealed  wells.  Following  optimization  of  the  growth
conditions,  best  diffraction-quality  crystals  were  routinely
grown at 23 °C from 0.1M MgCl2, 0.1M NaCl, 0.1M Tris-HCl
pH 8.0, 14%–22% PEG 4000 in a 3:1 protein:cocktail ratio.
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experiments were performed on the in-house R-AXIS IVC
image plate and rotating anode X-ray system, with the crystals
maintained both at ambient and cryogenic temperatures. X-
ray  diffraction  data  collection  was  performed  at  the  A-1
station  of  the  Cornell  High  Energy  Synchrotron  Source
(CHESS), Ithaca, New York. The crystals were cooled at
cryogenic temperature by plunging them into liquid nitrogen
and maintaining them in a stream of liquid nitrogen during
data  collection.  Glycerol  was  added  to  the  crystallization
droplets to adjust the final glycerol concentration to 40%–
50%. This liquid mixture served as the cryoprotectant for the
crystals. The diffraction images were recorded on an ADSC
Quantum-210 Charge Coupled Device (CCD) detector. The
diffraction  data  were  processed  with  HKL2000  [25]  and
MOSFLM [26] routines.
Ligand-binding  assays  by  fluorescence  spectroscopy:  The
binding  of  all-trans  retinol  to  Xenopus  IRBP  was
characterized  in  titrations  using  a  DM  45  scanning
spectrofluorimeter (Online Instrument Systems, Inc., Bogart,
Georgia) [27]. Titrations monitoring enhancement of retinol
fluorescence, quenching of the intrinsic protein fluorescence,
and energy transfer were performed as previously described
[28]. Enhancement of retinol fluorescence was followed by
monitoring the increase in retinol fluorescence (excitation:
330  nm;  emission:  480  nm)  compared  to  a  fluorescence-
matched solution of N-acetyl-L-tryptophanamide [29]. The
concentration  of  the  N-acetyl-L-tryptophanamide  solution
was  adjusted  to  match  the  fluorescence  of  the  apo-IRBP
solution. The fluorescence of all-trans retinol in the presence
of N-acetyl-L-tryptophanamide was subtracted from that in
the presence of xIRBP. Assays following quenching of protein
fluorescence used an excitation wavelength of 280 nm and an
emission wavelength of 340 nm. In these experiments the
inner filter effect was accounted for by graphical correction
[30]. Energy transfer assays monitored retinol fluorescence at
480 nm (excitation: 280 nm). The dissociation constant (Kd)
and number of binding sites (N) was determined by nonlinear
least square fit to a binding equation that assumed a single
type of noninteracting site(s) [31].
RESULTS
Stability and integrity of purified Xenopus interphotoreceptor
retinol-binding  protein:  The  expession  and  purification
procedure described in the previous section yielded 15 to
20 mg of ~97% pure xIRBP from 1.25 L of cell culture. A gel
electrophoresis of the final product is shown in Figure 1. In
contrast  to  previous  reports  of  xIRBP  instability  at  high
concentrations [32], the purified xIRBP, free of its fusion
partner  Trx,  maintained  its  integrity,  high  solubility,  and
ligand-binding ability for weeks at 4 °C at a concentration of
~10  mg/ml.  The  enhanced  protein  stability  and  sustained
solubility were partially attributable to the presence of molar
excess of DTT in solution. Furthermore, the absence of n-
octyl-β-D-glucopyranoside  or  any  other  detergent  was
probably a stabilizing factor as well, since for soluble proteins,
detergents  could  add  to  instability  promoting  gradual
unfolding.  Thus,  under  the  reducing  conditions  of  the
purification experiments, highly pure xIRBP maintained its
naturally folded stable tertiary structure, and, therefore, was
fully soluble and functionally active for a prolonged period of
time.
N-terminus sequence: The N-terminal sequence for the full-
length recombinant xIRBP was unambiguously determined to
be G-L-G-D-P-F-Q-P-S-L. The actual N-terminal sequence
of xIRBP is F-Q-P-S-L… The first part of the determined
sequence,  namely  G-L-G-D-P,  belonged  to  the  vector
pThioHisA  (Invitrogen)  that  was  included  in  the  cloning
sequence of xIRBP. This result, along with the molecular
weight of the protein band (Figure 1), confirmed the identity
of  the  purified  protein  to  be  the  full-length  recombinant
xIRBP, free of its fusion partner Trx.
Binding  assays  with  all-trans  retinol:  Binding  curves  for
fluorescence studies for binding of all-trans retinol are shown
Figure 1. Gel electrophoresis (SDS–PAGE; silver stained) analysis
of the purified four-module containing Xenopus interphotoreceptor
retinol-binding protein. The major band corresponds to monomeric
Xenopus  interphotoreceptor  retinol-binding  protein  (xIRBP)
molecular weight of 131 kDa. The minor higher molecular weight
band represents dimeric form of the protein, which may or may not
be an artifact of the analysis itself.
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2277in  Figure  2.  For  the  increase  in  retinol  fluorescence
measurements (excitation: 330 nm; emission: 480 nm), the
number  of  binding  sites  per  molecule  of  protein  (n)  was
1.30±0.04  with  Kd=0.15±0.03  μM.  Titration  monitoring
quenching  of  tryptophan  fluorescence  by  bound  retinol
(excitation:  280  nm;  emission:  340  nm)  yielded  binding
parameters n=1.32±0.06 and Kd=0.16 ± 0.04 μM. Finally, the
calculated  binding  parameters  were  n=1.05  ±  0.03  and
Kd=0.06± 0.01 μM for titration monitoring of energy transfer.
The retinol-binding data compare well with the data from
groups purifying the protein in the presence of DTT, albeit at
concentrations lower than the present work of Chen et al.
[33].  Older  studies,  which  apparently  did  not  include  a
reducing agent in the purification of xIRBP, tended to obtain
Figure  2.  Fluorescence  titrations  are  shown  of  Xenopus
interphotoreceptor retinol-binding protein (xIRBP) binding all-trans
retinol. The concentration of xIRBP was 0.89 μM in each panel. A:
The titration of IRBP with all-trans retinol in this panel is followed
by monitoring the increase in retinol fluorescence compared to a
fluorescence  matched  solution  of  N-acetyl-L-tryptophanamide
(excitation: 330 nm; emission: 480 nm). B: The titration shown
follows the quenching of intrinsic protein fluorescence by bound
retinol (excitation: 280 nm; emission: 340 nm). C: The titration
follows ligand binding by monitoring energy transfer (excitation:
280 nm; emission: 480 nm).
Figure 3. Photomicrographs of Xenopus interphotoreceptor retinol-
binding protein crystals grown in the presence of oleic acid. The
crystals were typically about 0.2 mm in the longest dimension.
values for N and Kd of roughly one site and 1 μM, respectively
[11,34].
Crystallization  and  X-ray  diffraction:  Single  crystals  of
xIRBP appeared in 5–10 days at 23 °C and continued to grow
for weeks. The crystals had two different morphologies: plate-
like and parallelepiped-shaped. The largest and best-formed
crystals were typically about 0.2 mm in the longest dimension.
Figure 3 is a photomicrograph of crystals of xIRBP that grew
from a buffer containing 0.1 M MgCl2, 0.1 M NaCl, 0.1 M
Tris-HCl  (pH8.0)  with  20%–22%  PEG  4000  as  the
precipitant, at 2:1 and 3:1 protein to reservoir ratios. A typical
diffraction image recorded with synchrotron X-rays at the
CHESS is shown in Figure 4. Crystals of both morphologies
had the same space group and showed similar diffraction
characteristics, typically to a resolution of about 2.45Å. The
space group was P21 and the cell parameters were a=93.53Å,
b=134.04Å, c=121.29Å, β=109.8°. There were two 131 kDa
polypeptide chains in the asymmetric unit, giving rise to a
specific volume of 2.65Å3/Da, which was within the range for
protein  crystals  [35].  From  one  crystal  a  total  of  180
diffraction images, each of 1° oscillation and 15 s exposure,
were  recorded  on  a  CCD  detector  yielding  318,878  total
observations  for  99,902  unique  reflections.  The  data  was
99.3% complete to 2.46Å resolution, with an Rmerge of 0.099.
Figure  4.  An  X-ray  diffraction  pattern  from  a  Xenopus
interphotoreceptor retinol-binding protein crystal recorded at the A-1
station of the Cornell High Energy Synchrotron Source. The detector
was at a distance 250 mm; the wavelength, the oscillation angle and
the exposure time were 0.978Å, 1°, and 15 s, respectively. The right
upper corner segment is shown in higher contrast to demonstrate the
limiting resolution of diffraction of ~2.45Å.
Molecular Vision : 13:2275-2281 <http://www.molvis.org/molvis/v13/a257> © 2007 Molecular Vision
2278The overall intensity to standard deviation ratio is 16.9 and
that in the highest resolution shell (2.55–2.46Å) is 3.6.
DISCUSSION
IRBP  is  the  only  known  retinoid-binding  protein  that
possesses a multiple domain structure. However, the exact
nature of its role has remained a mystery, owing partially to
the  lack  of  structural  insights  into  the  nature  of  binding
pockets,  and  correlation  of  the  functional  properties  with
structural  details.  Biochemical  and  homology  modeling
studies  suggest  that  the  ligand-binding  domains  in  each
module are not equivalent, and that the modules interact with
each  other  [24].  Thus,  understanding  IRBP’s  complex
function in the visual cycle will require a detailed knowledge
of the structural and functional relationships of its modules.
The structure of the xIRBP module 2 [36] has provided some
clues to that effect. Nonetheless, since a functional full-length
Xenopus  and  mammalian  IRBP  molecule  contains  four
homologous modules, these structures in the ligand-bound
form are likely to yield more comprehensive understanding of
the structure-function relationship. Our effort to investigate
the structure of full-length xIRBP in complex with fatty acids,
and retinoids is a step toward achieving that goal.
Determining the structure of IRBP has proven difficult.
First,  IRBP  is  large  (~131  kDa),  and  undergoes  ligand-
dependent conformational changes [37]. This together with its
glycosylation properties [38] could contribute to molecular
and  dynamical  heterogeneities.  Purification  of  tens  of
milligrams of xIRBP to high homogeneity and in pristine form
as well as successful growth of the high diffraction-quality
crystals demonstrate that by using the recombinant protein, a
bacterial  expression  system,  and  optimized  purification
strategies, we have been able to eliminate the heterogeneities
and instabilities of the past. The use of a thiol-based reducing
agent in prevention of denaturation is significant since IRBPs
contain several cysteine residues [39]. Homology modeling
of modules 1, 3, and 4 of xIRBP after the module 2 structure
suggests that many, if not all, of its seven cysteines do not
participate in disulfide formation and remain as free –SH
groups  exposed  to  the  solvent.  Interestingly,  of  the  10
cysteines  in  bovine  IRBP,  eight  were  experimentally
determined to have free –SH groups [39]. Our data for bovine
IRBP indicate that molecules aggregate, unfold, and denature
irreversibly by cross-linking through free sulfhydryl groups
(unpublished  results),  which  may  result  in  previously
observed limited solubility [32]. Although some enhancement
of solubility can be achieved by the addition of detergents,
such  as  n-octyl-β-D-glucopyranoside,  slow  precipitation
through denaturation of the protein cannot be prevented [32].
Although  the  function  of  IRBP’s  free  –SH  groups  are
unknown, it is plausible that they may have a role in IRBP’s
possible antioxidant activities for the protection of reduced
retinol molecules in the visual cycle [19].
The  all-trans  retinol  binding  results  derived  with  the
structurally pristine xIRBP from three separate experiments,
namely  (1)  enhancement  in  retinol  fluorescence,  (2)
quenching of intrinsic protein fluorescence, and (3) titration
monitoring of energy transfer, are internally consistent and
suggest roughly one retinol binding site per four-module full-
length molecule with a dissociation constant of about 0.1μM.
This data can be interpreted as the retinol-binding site being
restricted to one of the four modules, or to an intramodule site
defined by multiple modules, consistent with the notion that
not  all  four  modules  are  functionally  equivalent  as  the
homology  modeling  results  indicated.  Interestingly,
homology  modeling  identified  the  presence  of  a  highly
hydrophobic cavity, the so-called site I, suitable for retinol
binding in modules 1 and 2, and predicted that this site in
modules 3 and 4 may not exist [24]. Some differences between
the  two  retinol-binding  sites  in  modules  1  and  2  were
identified. It is likely that only one of these site I sites actually
binds  retinol,  and  the  other  is  unavailable  owing  to  the
quaternary association of the four modules. The second type
of sites in each module, the so-called site II, was more open,
hydrophilic,  and  predicted  to  be  lower  affinity  retinol  or
possibly fatty acid binding sites. Interestingly, the current
xIRBP crystals were grown in the presence of 0.5 mM oleic
acid, prompting us to speculate that binding of ligands to the
specific  sites  may  provide  additional  dynamical  stability
necessary  for  the  growth  of  diffraction-quality  crystals.
Efforts to grow xIRBP crystals in the presence of retinol and
other ligands are now in progress. Elucidation of the nature
and number of the ligand-binding sites and their implications
in overall IRBP function must await the determination of the
crystal structures of some of these complexes.
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